By Adria Calatayud
Danone is scheduled to report results for the fourth quarter and 2024 on Wednesday. Here is what you need to know.
SALES FORECAST: Analysts expect the French food company behind Activia yogurt and Evian water to report fourth-quarter sales of 6.59 billion euros ($6.90 billion) and like-for-like growth of 4.2%, according to consensus estimates provided by the company. For the same period a year earlier, the company reported sales of 6.66 billion euros with like-for-like sales growth of 5.1%.
PROFIT FORECAST: Danone is expected to report a full-year recurring net profit--which strips out exceptional and other one-off items--of 2.29 billion euros, according to the same consensus. For 2023, the company reported 2.28 billion euros.
Shares in Danone fell 0.3% during the fourth quarter of 2024, but the stock rose 6.8% in the year to date.
WHAT TO WATCH
--Danone is likely to have ended 2024 on a strong note and, heading into 2025, investors' focus will be on the extent to which Danone's sales volumes can keep rising as pricing picks up, analysts at JPMorgan said in a note. The company is expected to post like-for-like sales growth of 3.8% in 2025, according to consensus estimates provided by Visible Alpha. Analysts at Citi said their estimate on Danone's sales growth of 3.9% in 2025 is predicated on pricing returning to more positive dynamics by the second quarter.
--In a world in which consumers are more aware of health concerns after the Covid-19 pandemic, Danone is on the right side of the debate and this is translating into significant improvements in its sales volumes, analysts at Barclays said. Moreover, the company should gain from a boom in weight-loss drugs, the analysts said. However, investors will likely need data and evidence to support the idea that Danone is a beneficiary of weight-loss drugs in North America, the Citi analysts said.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
February 25, 2025 09:40 ET (14:40 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.